Skip to search formSkip to main contentSkip to account menu

teflutixol

Known as: 2-trifluormethyl-6-fluoro-9-(3-(4-(2-hydroxypiperazin-1-yl))propyl)thioxanthene 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
  • J. Hyttel
  • Psychopharmacology
  • 2004
  • Corpus ID: 22801301
The changes in 14C-dopamine accumulation formed from 14C-tyrosine in mice after treatment with three neuroleptics, cis (Z… 
2004
2004
  • J. Hyttel
  • Psychopharmacology
  • 2004
  • Corpus ID: 33245692
The specific binding of 3H-labelled haloperidol (3H-Hal) and the basal and dopamine-stimulated adenylate-cyclase activity in… 
1983
1983
  • L. Botte
  • Acta psychiatrica Belgica
  • 1983
  • Corpus ID: 11961124
A new thioxanthene derivative, teflutixol (Lu 10-022) has been administered for 4 weeks to 21 patients [12 schizophrenics, 6… 
1979
1979
  • J. Hyttel
  • Journal of Neurochemistry
  • 1979
  • Corpus ID: 40397256
Abstract— Four days after a single dose of teflutixol (5 mg/kg i.p.), at which time mice are superresponsive to dopamine agonists… 
1977
1977
The first thioxanthene derivative without the double bind up to now considered mandatory for the antipsychotic effect, teflutixol… 
1975
1975
  • J. Hyttel
  • Journal of Neurochemistry
  • 1975
  • Corpus ID: 30912828
—The long term effects on accumulation of 14C‐labelled dopamine and noradrenaline after [14C]tyrosine administration and on the…